Inside Innovation

Three life science companies with ties to Seattle were named to Fortune’s list of the 2021 most innovative and inventive pharmaceutical companies, which highlights companies

A Seattle office building was acquired by Toronto-based Oxford Properties Group, which intends to convert it into a fully dedicated life science facility. The purchase

Partners Rialto Capital of Miami and SteelWave LLC have bought Bothell-based Highlands Campus Tech Centre, home to Seagen, a leading biotech company that reported a

Icosavax Inc., a biotech company focused on vaccine development, announced a $100M Series B investment round. Icosavax, a spinout from the University of Washington plans

Impel NeuroPharma (Impel), a Seattle-based biotech company led by Adrian Adams, has indicated the company plans to go public. According to GeekWire, Impel filed paperwork

Outpace Bio, a biotech company based in Seattle, announced it has raised $30M in a Series A round, led by ARTIS Ventures and Lyell. Outpace,

OncoResponse, a Seattle biotech company focused on developing antibodies to make immunotherapy treatments, announced a $40.6M Series C investment round. The additional founding, led by

According to a new JLL report titled, “Life Sciences Emerging Markets Index: Poised for a paradigm shift,” Seattle is the fastest growing area for life

Washington is the fourth-best state in the U.S. for remote job seekers, according to a new study by CareerCloud. This ranking is based on data

Vancouver, Washington-based AbSci raised $125 million in a recent funding round, bringing the company’s total funding up to $230 million. The capital will further AbSci’s growth

Seattle startup Curi Bio raised $6 million in a Series A funding round to further develop its human stem cell-based platforms for drug discovery. The

Eliem Therapeutics, a clinical stage biotechnology company focused on developing therapies for neuronal excitability disorders, emerged from stealth with $80 million in capital and two